Sandoz Group AG
SDZNY | OTC
$86.12
+$1.21 (+1.43%)
Sep 22, 2026, 1:47 PM ET · Market open
Company Profile
No company profile available.
Key Executives
No executive data available
Contact Details
n/a
n/a
Stock Details
| Ticker Symbol | SDZNY |
| Exchange | n/a |
| Fiscal Year | n/a |
| Reporting Currency | n/a |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| SIC Code | n/a |
Recent News
- 4 days ago / prnewswire.commAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
- 4 days ago / wsj.comSandoz Gets Canada Approval for Generic Version of Ozempic
- 13 days ago / seekingalpha.comSandoz Group AG (SDZNY) Analyst/Investor Day Transcript
- 14 days ago / zacks.comGRFS or SDZNY: Which Is the Better Value Stock Right Now?
- 15 days ago / reuters.comSwitzerland's Sandoz pivots to biosimilars, expects rapid mid-term growth
- 26 days ago / zacks.com3 Generic Drug Stocks to Watch Amid Improving Industry Trends
- 1 month ago / prnewswire.comHenlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
- 1 month ago / reuters.comSandoz to license three biosimilar drugs from Shanghai Henlius Biotech
- 2 months ago / seekingalpha.comSandoz Group AG (SDZNY) Q2 2026 Earnings Call Transcript
- 2 months ago / wsj.comSandoz Shares Climb After Biosimilar Sales Drive Growth
Add to Watchlist
Select watchlists to add or remove SDZNY